Lonza received Good Manufacturing Practice Certification
Lonza Bioscience Singapore Pte Ltd announced that they have received cGMP certification from the Singapore Health Sciences Authority (HSA). The audit/conformity assessment, performed by the HSA, confirmed that Lonza Singapore has maintained an overall acceptable level of compliance with the Pharmaceutical Inspection Convention/Co-Operation Scheme (PIC/S) Guide to Good Manufacturing Practice (GMP) for Medicinal Products (Part I) relating to finished products. This encompasses all the recommendations of the World Health Organization (WHO) in relation to GMP.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Sequenom to Begin Clinical Assessment of Noninvasive Screening Technology for Down Syndrome
Frozen noble gas in the accelerator
Symyx Appoints New President of High Productivity Research
Nanomedicines on their way through the body - Which pathways do nanomedicines take after they have been swallowed?
AI model finds the cancer clues at lightning speed - Say goodbye to hours, even days, of detective work
Torsten Olschewski appointed as Business Unit Head at Analytik Jena AG
Rice's origins point to China, genome researchers conclude
The "new" kilogram is approaching - Avogadro constant determined with enriched silicon-28
Lighting up Alzheimer’s-related proteins to allow for earlier disease detection
Fluidigm-Singapore completes final milestone toward full manufacturing operations - Off-shore fab positions Fluidigm to move rapidly into the real-time qPCR market
Sartorius Stedim Biotech and Refine Technology Announce Cooperation